Looking forward to chairing NSORD2026 here in Halifax. Over 230 registrants! Some great speakers! Going to be an exciting day! #NSORD2026 @NSHealthHub @HealthNS @TimHoustonNS @CCSResearch
Ravi R 🇨🇦
@medoncdoc
Dad and Oncologist, MD PhD. Chair of HPB oncology Nova Scotia. Director of ACCRU. Director of Research Med Onc Halifax. My tweets are my own.
513 Following 710 Followers 2.6K Posts
Latest posts 5
A really important discussion on cancer drug costs and the effect on our Canadian cancer patient population! @CraigsCauseCan @CAMO_ACOM @cancersociety @pancreaticna His cancer drug costs $90,000/month. Doctors say it’s greed youtu.be/NNACZ1qs4lo?si… via @YouTube
www.youtube.com His cancer drug costs $90,000/month. Doctors say it’s greed Cancer doctors across Canada are sounding the alarm over drug price... Data seems to confirm that adjuvant cis/gem is no better than cape. I wonder if immunotherapy will have a role in the adjuvant BTC space.
Much anticipated ACTICCA-1
➡️adj cis/gem v cape #BTC
➡️mod ITT n=591
➡️no diff in DFS at 24mth 52% v 44%
RMST at 3 yrs ⬆️DFS by 2.6mth
➡️28% iCCA -no maj subgroup diff
➡️mOS 58.1 v 48.2 p=0.1
❎No change to std ?an option, NB need as backbone 1st line!
@myESMO @OncoAlert #ESMO26View quoted post on X
Small grounds being made in pancreatic, bile duct and liver cancer.. but at least it’s something!
The top cancer success stories of the past 50 years, by the numbers
nature.com/articles/d4158…View quoted post on X
Wow. What an amazing outcome! And they said KRAS mutations are never going to be drugable! #Pancreaticcancer @CraigsCauseCan @PanCAN Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer | New England Journal of Medicine nejm.org/doi/full/10.10…
www.nejm.org Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer | NEJM Current therapies offer limited benefit for patients with previously treated metastatic pancreatic ductal adenocarcinoma (mPDAC). Aberrant activation of the RAS pathway is the key driver of PDAC, w...